Inventor · disambiguated record
Caroline Breitbach
Also filed as: BREITBACH CAROLINE · BREITBACH CAROLINE J · BREITBACH CAROLINE JUDITH
5 granted patents·4 pending applications·26 citations·filing 2007–2023
75Inventor score
Files withOTTAWA HOSPITAL RES INST4KIRN DAVID2SILLAJEN BIOTHERAPEUTICS INC2OTTAWA HEALTH RESEARCH INST1
Top patents by PatentIndex Score
9 records- 0189US8747837B2Oncolytic vaccinia virus combination cancer therapyKIRN DAVID·Filed 2010·Granted Jun 10, 2014·18 cites·15 claims
- 0279US9919047B2Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virusKIRN DAVID·Filed 2012·Granted Mar 20, 2018·5 cites·24 claims
- 0374US9180151B2Oncolytic vaccinia virus combination cancer therapySILLAJEN BIOTHERAPEUTICS INC·Filed 2014·Granted Nov 10, 2015·2 cites·22 claims
- 0472US10434169B2Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virusSILLAJEN BIOTHERAPEUTICS INC·Filed 2018·Granted Oct 8, 2019·1 cites·13 claims
- 0563US2024229069A9Modified orthopoxvirus vectorsOTTAWA HOSPITAL RES INST·Filed 2023·Application pending·0 cites
- 0653US11802292B2Modified orthopoxvirus vectorsOTTAWA HOSPITAL RES INST·Filed 2019·Granted Oct 31, 2023·0 cites·50 claims
- 0749US2022380799A1Modified orthopoxvirus vectorsOTTAWA HOSPITAL RES INST·Filed 2019·Application pending·0 cites
- 0847US2022056480A1Modified orthopoxvirus vectorsOTTAWA HOSPITAL RES INST·Filed 2019·Application pending·0 cites
- 0944US2011044937A1Staged immune-response modulation in oncolytic therapyOTTAWA HEALTH RESEARCH INST·Filed 2007·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →